Vascular event risks of DPP-4 inhibitors in Japanese patients with type 2 diabetes: a comparative effectiveness study using a large scale hospital database

Vascular event risks of DPP-4 inhibitors in Japanese patients with type 2 diabetes: a comparative effectiveness study using a large scale hospital database - Vascular risks of DPP-4 inhibitors

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015361

Enrollment

100000

Registered

2014-10-09

Start date

2014-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Having diagnosis codes for type 2 diabetes (ICD-10 E11, E12, E13, and E14) 2. New users of anti-diabetic medicines

Exclusion criteria

Exclusion criteria: 2. Having diagnosis code of ICD-10 E10 for type 1 diabetes

Design outcomes

Primary

Measure	Time frame
Composite endpoint including cardiac infarction, cerebral infarction, and cerebral hemorrhage.	—

Secondary

Measure	Time frame
individual vascular events including cardiac infarction, cerebral infarction, and cerebral hemorrhage.	—

Countries

Japan

Contacts

Public ContactHisashi Urushihara

Keio University Drug Development and Regulatory Science, Faculty of Pharmacy

urushihara-hs@pha.keio.ac.jp03-5400-2649

Outcome results